BMRN vs KNSL · P/E 40, rev $1.76B vs P/E 13, rev $1.02B
Biomarin Pharmaceutical Inc (BMRN) versus Kinsale Capital Group Inc (KNSL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Kinsale Capital Group Inc (KNSL) is a insurance - property & casualty company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported KNSL revenue for 2026-06-30 was $1.02B. Net income was $288.4M. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
Not investment advice. Open the BMRN and KNSL stock pages for the full models.
Not investment advice.